BioCardia Inc (BCDA)
2.366
-0.03
(-1.43%)
USD |
NASDAQ |
Nov 07, 16:00
2.37
0.00 (0.00%)
After-Hours: 20:00
BioCardia Revenue (TTM): 0.428M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.428M |
| March 31, 2024 | 0.468M |
| December 31, 2023 | 0.477M |
| September 30, 2023 | 0.57M |
| June 30, 2023 | 0.425M |
| March 31, 2023 | 1.356M |
| December 31, 2022 | 1.352M |
| September 30, 2022 | 1.325M |
| June 30, 2022 | 1.934M |
| March 31, 2022 | 1.029M |
| December 31, 2021 | 1.015M |
| September 30, 2021 | 0.982M |
| June 30, 2021 | 0.195M |
| March 31, 2021 | 0.153M |
| December 31, 2020 | 0.145M |
| September 30, 2020 | 0.314M |
| June 30, 2020 | 0.474M |
| March 31, 2020 | 0.533M |
| December 31, 2019 | 0.711M |
| September 30, 2019 | 0.599M |
| June 30, 2019 | 0.489M |
| March 31, 2019 | 0.642M |
| December 31, 2018 | 0.625M |
| September 30, 2018 | 0.622M |
| June 30, 2018 | 0.668M |
| Date | Value |
|---|---|
| March 31, 2018 | 0.541M |
| December 31, 2017 | 0.479M |
| September 30, 2017 | -4.836M |
| June 30, 2017 | 0.534M |
| March 31, 2017 | 0.564M |
| December 31, 2016 | 0.576M |
| September 30, 2016 | 5.926M |
| June 30, 2016 | 0.547M |
| March 31, 2016 | 0.53M |
| December 31, 2015 | 0.517M |
| September 30, 2015 | 0.51M |
| June 30, 2015 | 0.485M |
| March 31, 2015 | 0.465M |
| December 31, 2014 | 0.427M |
| September 30, 2014 | 0.389M |
| June 30, 2014 | 0.364M |
| March 31, 2014 | 0.328M |
| December 31, 2013 | 0.268M |
| September 30, 2013 | 0.193M |
| June 30, 2013 | 0.141M |
| March 31, 2013 | 0.089M |
| December 31, 2012 | 0.062M |
| September 30, 2012 | 0.059M |
| June 30, 2012 | |
| March 31, 2012 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.145M
Minimum
Dec 2020
1.934M
Maximum
Jun 2022
0.7308M
Average
0.533M
Median
Mar 2020
Revenue (TTM) Benchmarks
| Alnylam Pharmaceuticals Inc | 2.095B |
| Theriva Biologics Inc | -- |
| Zevra Therapeutics Inc | 23.99M |
| PetIQ Inc | 1.134B |
| Instil Bio Inc | -- |